| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 3.11e-07 | 14 | 20 | 3 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 1.50e-06 | 23 | 20 | 3 | GO:0034235 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 3.09e-06 | 29 | 20 | 3 | GO:0035325 | |
| GeneOntologyMolecularFunction | filamin binding | 3.09e-06 | 29 | 20 | 3 | GO:0031005 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.04e-06 | 34 | 20 | 3 | GO:0015125 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.54e-05 | 49 | 20 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | protein-glutamine gamma-glutamyltransferase activity | 3.42e-05 | 9 | 20 | 2 | GO:0003810 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 4.51e-05 | 70 | 20 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 4.77e-05 | 207 | 20 | 4 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 4.86e-05 | 208 | 20 | 4 | GO:0005342 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 5.11e-05 | 73 | 20 | 3 | GO:0170055 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 9.55e-05 | 90 | 20 | 3 | GO:0008028 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.83e-04 | 293 | 20 | 4 | GO:0008514 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 4.23e-04 | 149 | 20 | 3 | GO:1990782 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 6.54e-04 | 173 | 20 | 3 | GO:0070851 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 9.39e-04 | 196 | 20 | 3 | GO:0005319 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 1.15e-03 | 210 | 20 | 3 | GO:0019903 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.49e-03 | 230 | 20 | 3 | GO:0005516 | |
| GeneOntologyMolecularFunction | phosphatase binding | 2.21e-03 | 264 | 20 | 3 | GO:0019902 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 3.67e-03 | 316 | 20 | 3 | GO:0035091 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 3.93e-03 | 324 | 20 | 3 | GO:0005126 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 6.96e-03 | 398 | 20 | 3 | GO:0046982 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 7.91e-03 | 815 | 20 | 4 | GO:0042803 | |
| GeneOntologyMolecularFunction | actin binding | 1.15e-02 | 479 | 20 | 3 | GO:0003779 | |
| GeneOntologyMolecularFunction | lipid binding | 1.53e-02 | 988 | 20 | 4 | GO:0008289 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.66e-02 | 548 | 20 | 3 | GO:0005543 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 2.82e-07 | 14 | 20 | 3 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 3.52e-07 | 15 | 20 | 3 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.52e-07 | 15 | 20 | 3 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 3.52e-07 | 15 | 20 | 3 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 3.52e-07 | 15 | 20 | 3 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 4.33e-07 | 16 | 20 | 3 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 5.26e-07 | 17 | 20 | 3 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 5.26e-07 | 17 | 20 | 3 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 5.26e-07 | 17 | 20 | 3 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 6.30e-07 | 18 | 20 | 3 | GO:1903385 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 6.32e-07 | 178 | 20 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 8.79e-07 | 20 | 20 | 3 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.03e-06 | 21 | 20 | 3 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.03e-06 | 21 | 20 | 3 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.03e-06 | 21 | 20 | 3 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 1.19e-06 | 22 | 20 | 3 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 1.24e-06 | 85 | 20 | 4 | GO:1903670 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 1.36e-06 | 87 | 20 | 4 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 1.36e-06 | 23 | 20 | 3 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.36e-06 | 23 | 20 | 3 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 1.56e-06 | 24 | 20 | 3 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 1.56e-06 | 24 | 20 | 3 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 1.56e-06 | 24 | 20 | 3 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 1.77e-06 | 25 | 20 | 3 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 1.77e-06 | 25 | 20 | 3 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 2.25e-06 | 27 | 20 | 3 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 2.51e-06 | 28 | 20 | 3 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 2.80e-06 | 29 | 20 | 3 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 3.44e-06 | 31 | 20 | 3 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.80e-06 | 32 | 20 | 3 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 3.80e-06 | 32 | 20 | 3 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.80e-06 | 32 | 20 | 3 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 4.18e-06 | 33 | 20 | 3 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 4.18e-06 | 33 | 20 | 3 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.58e-06 | 34 | 20 | 3 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 4.58e-06 | 34 | 20 | 3 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.00e-06 | 35 | 20 | 3 | GO:1901142 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 5.96e-06 | 126 | 20 | 4 | GO:1903035 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 6.44e-06 | 38 | 20 | 3 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 6.97e-06 | 39 | 20 | 3 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 7.53e-06 | 40 | 20 | 3 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 8.12e-06 | 41 | 20 | 3 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 8.74e-06 | 42 | 20 | 3 | GO:0090330 | |
| GeneOntologyBiologicalProcess | gland development | 1.07e-05 | 558 | 20 | 6 | GO:0048732 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 1.08e-05 | 45 | 20 | 3 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 1.15e-05 | 46 | 20 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 1.15e-05 | 46 | 20 | 3 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 1.23e-05 | 47 | 20 | 3 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 1.23e-05 | 47 | 20 | 3 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 1.23e-05 | 47 | 20 | 3 | GO:0034104 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 1.40e-05 | 49 | 20 | 3 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.40e-05 | 49 | 20 | 3 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.48e-05 | 50 | 20 | 3 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 1.67e-05 | 52 | 20 | 3 | GO:0031342 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 1.77e-05 | 53 | 20 | 3 | GO:0034110 | |
| GeneOntologyBiologicalProcess | regulation of wound healing | 1.77e-05 | 166 | 20 | 4 | GO:0061041 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 2.09e-05 | 56 | 20 | 3 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.45e-05 | 59 | 20 | 3 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.58e-05 | 60 | 20 | 3 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 2.58e-05 | 60 | 20 | 3 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 2.71e-05 | 61 | 20 | 3 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.43e-05 | 66 | 20 | 3 | GO:0010543 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 3.59e-05 | 67 | 20 | 3 | GO:0045601 | |
| GeneOntologyBiologicalProcess | liver development | 3.83e-05 | 202 | 20 | 4 | GO:0001889 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.92e-05 | 69 | 20 | 3 | GO:0030195 | |
| GeneOntologyBiologicalProcess | hepaticobiliary system development | 4.05e-05 | 205 | 20 | 4 | GO:0061008 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 4.09e-05 | 70 | 20 | 3 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 4.09e-05 | 70 | 20 | 3 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 4.27e-05 | 71 | 20 | 3 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 4.27e-05 | 71 | 20 | 3 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 4.46e-05 | 72 | 20 | 3 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 4.46e-05 | 72 | 20 | 3 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 4.64e-05 | 73 | 20 | 3 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of response to wounding | 5.06e-05 | 217 | 20 | 4 | GO:1903034 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell differentiation | 5.06e-05 | 217 | 20 | 4 | GO:0030856 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 5.24e-05 | 76 | 20 | 3 | GO:0042269 | |
| GeneOntologyBiologicalProcess | sprouting angiogenesis | 5.34e-05 | 220 | 20 | 4 | GO:0002040 | |
| GeneOntologyBiologicalProcess | cellular response to nitrogen compound | 5.76e-05 | 752 | 20 | 6 | GO:1901699 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 6.11e-05 | 80 | 20 | 3 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 6.11e-05 | 80 | 20 | 3 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 6.82e-05 | 83 | 20 | 3 | GO:0002707 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 7.32e-05 | 85 | 20 | 3 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 7.58e-05 | 86 | 20 | 3 | GO:0042058 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 8.97e-05 | 91 | 20 | 3 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 8.97e-05 | 91 | 20 | 3 | GO:0030193 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 9.57e-05 | 93 | 20 | 3 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 9.57e-05 | 93 | 20 | 3 | GO:1901184 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 1.02e-04 | 95 | 20 | 3 | GO:0070527 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 1.05e-04 | 262 | 20 | 4 | GO:0048771 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 1.05e-04 | 96 | 20 | 3 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 1.05e-04 | 96 | 20 | 3 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 1.12e-04 | 98 | 20 | 3 | GO:0061045 | |
| GeneOntologyBiologicalProcess | bone resorption | 1.15e-04 | 99 | 20 | 3 | GO:0045453 | |
| GeneOntologyBiologicalProcess | cellular response to insulin stimulus | 1.20e-04 | 271 | 20 | 4 | GO:0032869 | |
| GeneOntologyBiologicalProcess | response to peptide hormone | 1.24e-04 | 530 | 20 | 5 | GO:0043434 | |
| GeneOntologyBiologicalProcess | response to nitrogen compound | 1.27e-04 | 1272 | 20 | 7 | GO:1901698 | |
| GeneOntologyBiologicalProcess | ketone metabolic process | 1.34e-04 | 279 | 20 | 4 | GO:0042180 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 1.37e-04 | 105 | 20 | 3 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 1.45e-04 | 107 | 20 | 3 | GO:0042130 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 1.53e-04 | 109 | 20 | 3 | GO:0002228 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 4.16e-07 | 16 | 20 | 3 | GO:0070021 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.34e-05 | 90 | 20 | 3 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 1.07e-04 | 98 | 20 | 3 | GO:0060170 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 4.31e-04 | 157 | 20 | 3 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 4.81e-04 | 163 | 20 | 3 | GO:0042101 | |
| GeneOntologyCellularComponent | protein kinase complex | 5.44e-04 | 170 | 20 | 3 | GO:1902911 | |
| GeneOntologyCellularComponent | adherens junction | 1.03e-03 | 212 | 20 | 3 | GO:0005912 | |
| GeneOntologyCellularComponent | apical part of cell | 2.15e-03 | 592 | 20 | 4 | GO:0045177 | |
| GeneOntologyCellularComponent | basolateral plasma membrane | 3.34e-03 | 320 | 20 | 3 | GO:0016323 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 3.80e-03 | 335 | 20 | 3 | GO:0061695 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 4.29e-03 | 350 | 20 | 3 | GO:0098802 | |
| GeneOntologyCellularComponent | basal plasma membrane | 4.43e-03 | 354 | 20 | 3 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 5.32e-03 | 378 | 20 | 3 | GO:0045178 | |
| GeneOntologyCellularComponent | cell projection membrane | 7.64e-03 | 431 | 20 | 3 | GO:0031253 | |
| GeneOntologyCellularComponent | cilium | 9.45e-03 | 898 | 20 | 4 | GO:0005929 | |
| GeneOntologyCellularComponent | apical plasma membrane | 1.07e-02 | 487 | 20 | 3 | GO:0016324 | |
| GeneOntologyCellularComponent | anchoring junction | 1.26e-02 | 976 | 20 | 4 | GO:0070161 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.27e-02 | 519 | 20 | 3 | GO:0009897 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 6.74e-07 | 17 | 15 | 3 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 1.31e-06 | 21 | 15 | 3 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 2.00e-06 | 24 | 15 | 3 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 2.88e-06 | 27 | 15 | 3 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 3.22e-06 | 28 | 15 | 3 | MP:0020950 | |
| MousePheno | decreased carbon dioxide production | 4.41e-06 | 31 | 15 | 3 | MP:0008964 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 4.41e-06 | 31 | 15 | 3 | MP:0031413 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 6.41e-06 | 35 | 15 | 3 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 6.99e-06 | 36 | 15 | 3 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 8.93e-06 | 39 | 15 | 3 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 1.29e-05 | 44 | 15 | 3 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.58e-05 | 47 | 15 | 3 | MP:0031617 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.79e-05 | 49 | 15 | 3 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 2.27e-05 | 53 | 15 | 3 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 2.40e-05 | 54 | 15 | 3 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 3.30e-05 | 60 | 15 | 3 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 3.47e-05 | 61 | 15 | 3 | MP:0010951 | |
| MousePheno | increased insulin secretion | 4.00e-05 | 64 | 15 | 3 | MP:0003058 | |
| MousePheno | abnormal muscle cell glucose uptake | 4.60e-05 | 67 | 15 | 3 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 4.60e-05 | 67 | 15 | 3 | MP:0008962 | |
| MousePheno | abnormal vascular wound healing | 5.94e-05 | 73 | 15 | 3 | MP:0004883 | |
| MousePheno | decreased oxygen consumption | 7.53e-05 | 79 | 15 | 3 | MP:0005290 | |
| MousePheno | polyphagia | 7.82e-05 | 80 | 15 | 3 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection | 8.41e-05 | 82 | 15 | 3 | MP:0020914 | |
| MousePheno | impaired glucose tolerance | 1.06e-04 | 480 | 15 | 5 | MP:0005293 | |
| MousePheno | abnormal cellular glucose uptake | 1.61e-04 | 102 | 15 | 3 | MP:0003925 | |
| MousePheno | abnormal large intestine morphology | 1.71e-04 | 276 | 15 | 4 | MP:0000489 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 1.96e-04 | 286 | 15 | 4 | MP:0008873 | |
| MousePheno | decreased respiratory quotient | 2.01e-04 | 110 | 15 | 3 | MP:0010379 | |
| MousePheno | obese | 2.18e-04 | 113 | 15 | 3 | MP:0001261 | |
| MousePheno | decreased energy expenditure | 2.54e-04 | 119 | 15 | 3 | MP:0004890 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 2.60e-04 | 120 | 15 | 3 | MP:0009786 | |
| MousePheno | increased circulating leptin level | 2.94e-04 | 125 | 15 | 3 | MP:0005669 | |
| MousePheno | decreased susceptibility to viral infection | 2.94e-04 | 125 | 15 | 3 | MP:0002410 | |
| MousePheno | increased incidence of tumors by chemical induction | 4.18e-04 | 141 | 15 | 3 | MP:0004499 | |
| MousePheno | increased triglyceride level | 4.42e-04 | 354 | 15 | 4 | MP:0005317 | |
| MousePheno | increased lean body mass | 4.42e-04 | 354 | 15 | 4 | MP:0003960 | |
| MousePheno | abnormal glycogen homeostasis | 4.45e-04 | 144 | 15 | 3 | MP:0005438 | |
| MousePheno | increased total tissue mass | 4.92e-04 | 364 | 15 | 4 | MP:0012323 | |
| MousePheno | increased body weight | 4.92e-04 | 364 | 15 | 4 | MP:0001260 | |
| MousePheno | abnormal colon morphology | 5.21e-04 | 152 | 15 | 3 | MP:0000495 | |
| MousePheno | abnormal muscle morphology | 6.49e-04 | 1106 | 15 | 6 | MP:0002108 | |
| MousePheno | abnormal insulin secretion | 7.34e-04 | 171 | 15 | 3 | MP:0003564 | |
| MousePheno | increased incidence of induced tumors | 7.60e-04 | 173 | 15 | 3 | MP:0002021 | |
| MousePheno | increased body size | 7.63e-04 | 409 | 15 | 4 | MP:0001264 | |
| MousePheno | abnormal endocrine pancreas secretion | 7.99e-04 | 176 | 15 | 3 | MP:0014195 | |
| MousePheno | neoplasm | 8.24e-04 | 747 | 15 | 5 | MP:0002006 | |
| MousePheno | abnormal respiratory quotient | 8.25e-04 | 178 | 15 | 3 | MP:0004129 | |
| MousePheno | abnormal lean body mass | 8.34e-04 | 749 | 15 | 5 | MP:0003959 | |
| MousePheno | abnormal pancreas secretion | 8.94e-04 | 183 | 15 | 3 | MP:0002694 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 9.37e-04 | 186 | 15 | 3 | MP:0020912 | |
| MousePheno | increased food intake | 9.82e-04 | 189 | 15 | 3 | MP:0011939 | |
| MousePheno | abnormal wound healing | 1.04e-03 | 193 | 15 | 3 | MP:0005023 | |
| MousePheno | abnormal glucose tolerance | 1.04e-03 | 787 | 15 | 5 | MP:0005291 | |
| MousePheno | abnormal oxygen consumption | 1.07e-03 | 195 | 15 | 3 | MP:0005288 | |
| MousePheno | abnormal pancreatic beta cell physiology | 1.09e-03 | 196 | 15 | 3 | MP:0003562 | |
| MousePheno | insulin resistance | 1.11e-03 | 197 | 15 | 3 | MP:0005331 | |
| MousePheno | abnormal endocrine pancreas physiology | 1.19e-03 | 202 | 15 | 3 | MP:0010147 | |
| MousePheno | abnormal mitochondrial ATP synthesis coupled electron transport | 1.49e-03 | 54 | 15 | 2 | MP:0010956 | |
| MousePheno | abnormal circulating insulin level | 1.67e-03 | 505 | 15 | 4 | MP:0001560 | |
| MousePheno | abnormal skeletal muscle morphology | 1.71e-03 | 508 | 15 | 4 | MP:0000759 | |
| MousePheno | abnormal circulating leptin level | 1.86e-03 | 236 | 15 | 3 | MP:0005667 | |
| MousePheno | abnormal intestine morphology | 2.23e-03 | 546 | 15 | 4 | MP:0000477 | |
| MousePheno | decreased susceptibility to infection | 2.32e-03 | 255 | 15 | 3 | MP:0002409 | |
| MousePheno | abnormal abdominal fat pad morphology | 2.51e-03 | 262 | 15 | 3 | MP:0000010 | |
| MousePheno | abnormal incidence of induced tumors | 2.70e-03 | 269 | 15 | 3 | MP:0013151 | |
| MousePheno | decreased circulating triglyceride level | 2.88e-03 | 275 | 15 | 3 | MP:0002644 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 3.00e-03 | 279 | 15 | 3 | MP:0009785 | |
| MousePheno | abnormal susceptibility to viral infection | 3.00e-03 | 279 | 15 | 3 | MP:0020185 | |
| MousePheno | increased circulating insulin level | 3.12e-03 | 283 | 15 | 3 | MP:0002079 | |
| MousePheno | abnormal gas homeostasis | 3.14e-03 | 600 | 15 | 4 | MP:0003948 | |
| MousePheno | abnormal oxidative phosphorylation | 3.16e-03 | 79 | 15 | 2 | MP:0010959 | |
| MousePheno | hindlimb paralysis | 3.16e-03 | 79 | 15 | 2 | MP:0000755 | |
| MousePheno | abnormal response to injury | 3.28e-03 | 607 | 15 | 4 | MP:0005164 | |
| MousePheno | abnormal pancreas physiology | 3.41e-03 | 292 | 15 | 3 | MP:0002693 | |
| MousePheno | limb paralysis | 3.48e-03 | 83 | 15 | 2 | MP:0013147 | |
| MousePheno | abnormal triglyceride level | 3.94e-03 | 639 | 15 | 4 | MP:0000187 | |
| MousePheno | abnormal energy expenditure | 4.14e-03 | 313 | 15 | 3 | MP:0005450 | |
| MousePheno | abnormal fat pad morphology | 4.18e-03 | 314 | 15 | 3 | MP:0005334 | |
| MousePheno | abnormal physiological response to xenobiotic | 4.48e-03 | 662 | 15 | 4 | MP:0008872 | |
| MousePheno | abnormal energy homeostasis | 4.48e-03 | 322 | 15 | 3 | MP:0005448 | |
| MousePheno | abnormal respiratory electron transport chain | 4.62e-03 | 96 | 15 | 2 | MP:0010955 | |
| MousePheno | astrocytosis | 5.30e-03 | 103 | 15 | 2 | MP:0003354 | |
| MousePheno | decreased triglyceride level | 5.57e-03 | 348 | 15 | 3 | MP:0005318 | |
| MousePheno | increased astrocyte number | 5.71e-03 | 107 | 15 | 2 | MP:0012065 | |
| MousePheno | abnormal astrocyte number | 6.24e-03 | 112 | 15 | 2 | MP:0012064 | |
| MousePheno | abnormal endocrine gland physiology | 6.26e-03 | 363 | 15 | 3 | MP:0013561 | |
| MousePheno | abnormal induced morbidity/mortality | 6.56e-03 | 737 | 15 | 4 | MP:0001657 | |
| MousePheno | paralysis | 7.02e-03 | 119 | 15 | 2 | MP:0000753 | |
| Domain | Transglut_N | 3.51e-05 | 9 | 19 | 2 | PF00868 | |
| Domain | TRANSGLUTAMINASES | 3.51e-05 | 9 | 19 | 2 | PS00547 | |
| Domain | Transglutaminase_N | 3.51e-05 | 9 | 19 | 2 | IPR001102 | |
| Domain | Gln_gamma-glutamylTfrase_euk | 3.51e-05 | 9 | 19 | 2 | IPR023608 | |
| Domain | Transglutaminase_AS | 3.51e-05 | 9 | 19 | 2 | IPR013808 | |
| Domain | Transglut_C | 3.51e-05 | 9 | 19 | 2 | PF00927 | |
| Domain | - | 3.51e-05 | 9 | 19 | 2 | 3.90.260.10 | |
| Domain | Transglutaminase_C | 4.39e-05 | 10 | 19 | 2 | IPR008958 | |
| Domain | Ig_2 | 5.31e-05 | 73 | 19 | 3 | PF13895 | |
| Domain | TGc | 5.36e-05 | 11 | 19 | 2 | SM00460 | |
| Domain | Transglut_core | 5.36e-05 | 11 | 19 | 2 | PF01841 | |
| Domain | Transglutaminase-like | 5.36e-05 | 11 | 19 | 2 | IPR002931 | |
| Domain | - | 4.27e-04 | 663 | 19 | 5 | 2.60.40.10 | |
| Domain | Ig-like_fold | 5.69e-04 | 706 | 19 | 5 | IPR013783 | |
| Domain | V-set | 8.11e-04 | 184 | 19 | 3 | PF07686 | |
| Domain | Immunoglobulin | 8.91e-04 | 190 | 19 | 3 | IPR013151 | |
| Domain | ig | 8.91e-04 | 190 | 19 | 3 | PF00047 | |
| Domain | Ig_V-set | 1.02e-03 | 199 | 19 | 3 | IPR013106 | |
| Domain | Ig_sub2 | 1.64e-03 | 235 | 19 | 3 | IPR003598 | |
| Domain | IGc2 | 1.64e-03 | 235 | 19 | 3 | SM00408 | |
| Domain | Ig_E-set | 4.94e-03 | 104 | 19 | 2 | IPR014756 | |
| Domain | Ig_sub | 8.42e-03 | 421 | 19 | 3 | IPR003599 | |
| Domain | IG | 8.42e-03 | 421 | 19 | 3 | SM00409 | |
| Domain | IG_LIKE | 1.28e-02 | 491 | 19 | 3 | PS50835 | |
| Domain | Ig-like_dom | 1.36e-02 | 503 | 19 | 3 | IPR007110 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 1.44e-04 | 99 | 15 | 3 | MM14624 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 5.69e-04 | 158 | 15 | 3 | MM14812 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 9.44e-04 | 188 | 15 | 3 | MM15828 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.03e-03 | 194 | 15 | 3 | M16312 | |
| Pubmed | 9.09e-09 | 8 | 20 | 3 | 1690992 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 26219866 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 4.63e-08 | 13 | 20 | 3 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 4.63e-08 | 13 | 20 | 3 | 1985902 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 15207636 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 7628460 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 19285068 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 25724769 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 18003729 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 21760897 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 26284027 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 2133556 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 32521208 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 26374765 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 1719235 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 4.63e-08 | 13 | 20 | 3 | 33352461 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 19406938 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 10964771 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 38381498 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 32169849 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 20739537 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 4.63e-08 | 13 | 20 | 3 | 19273835 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 19621080 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 4.63e-08 | 13 | 20 | 3 | 25972571 | |
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 4.63e-08 | 13 | 20 | 3 | 29967450 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 4.63e-08 | 13 | 20 | 3 | 16638824 | |
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 4.63e-08 | 13 | 20 | 3 | 1326665 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 20044046 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 1633107 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 32150576 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 21081647 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 4.63e-08 | 13 | 20 | 3 | 39168268 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 22469976 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 11483763 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 4.63e-08 | 13 | 20 | 3 | 19358828 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 4.63e-08 | 13 | 20 | 3 | 21532628 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 4.63e-08 | 13 | 20 | 3 | 27695943 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 4.63e-08 | 13 | 20 | 3 | 28035001 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 4.63e-08 | 13 | 20 | 3 | 12832451 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 4.63e-08 | 13 | 20 | 3 | 15316023 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 8402684 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 20404914 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 4.63e-08 | 13 | 20 | 3 | 22092845 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 16680193 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 4.63e-08 | 13 | 20 | 3 | 21670291 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 22162753 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 11801635 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 2164599 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 26911181 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 1653760 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 4.63e-08 | 13 | 20 | 3 | 23935487 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 2702644 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 28913658 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 16619040 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 4.63e-08 | 13 | 20 | 3 | 32027621 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 19008452 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 8380065 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 18544705 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 1279194 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 4.63e-08 | 13 | 20 | 3 | 27777319 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 15331748 | ||
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 29377208 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 4.63e-08 | 13 | 20 | 3 | 15220458 | |
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 4.63e-08 | 13 | 20 | 3 | 8209741 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 4.63e-08 | 13 | 20 | 3 | 22406619 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 18848945 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 4.63e-08 | 13 | 20 | 3 | 8500759 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 4.63e-08 | 13 | 20 | 3 | 21949477 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 4.63e-08 | 13 | 20 | 3 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 4.63e-08 | 13 | 20 | 3 | 23800882 | |
| Pubmed | 4.63e-08 | 13 | 20 | 3 | 29396368 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 37531413 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 5.90e-08 | 14 | 20 | 3 | 18794798 | |
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 23780386 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 28567513 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 31083261 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 8207827 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 23469261 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 18454175 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 1648219 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 5.90e-08 | 14 | 20 | 3 | 26196244 | |
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 10491101 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 5.90e-08 | 14 | 20 | 3 | 17081782 | |
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 5.90e-08 | 14 | 20 | 3 | 34666041 | |
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 8896983 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 19700760 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 22159884 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 34619794 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 29907459 | ||
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 5.90e-08 | 14 | 20 | 3 | 32209360 | |
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 22962327 | ||
| Pubmed | 5.90e-08 | 14 | 20 | 3 | 17623671 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.57e-03 | 1192 | 20 | 4 | chr19q13 | |
| Cytoband | 19q13.2 | 2.31e-03 | 164 | 20 | 2 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 7.59e-08 | 11 | 15 | 3 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 8.04e-06 | 163 | 15 | 4 | 590 | |
| GeneFamily | Transglutaminases | 2.31e-05 | 9 | 15 | 2 | 773 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 4.69e-08 | 48 | 20 | 4 | MM531 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 1.86e-06 | 32 | 20 | 3 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 2.45e-06 | 35 | 20 | 3 | MM757 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 9.99e-06 | 182 | 20 | 4 | MM993 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 1.48e-05 | 201 | 20 | 4 | MM1006 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 2.07e-05 | 219 | 20 | 4 | MM3826 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 2.26e-05 | 224 | 20 | 4 | M40145 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 2.48e-05 | 75 | 20 | 3 | MM605 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 3.87e-05 | 87 | 20 | 3 | MM851 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 4.72e-05 | 93 | 20 | 3 | M40279 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 5.70e-05 | 284 | 20 | 4 | MM987 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 7.24e-05 | 302 | 20 | 4 | MM16604 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 1.22e-04 | 128 | 20 | 3 | MM1000 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.43e-04 | 135 | 20 | 3 | MM965 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 1.69e-04 | 143 | 20 | 3 | MM989 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 2.31e-04 | 159 | 20 | 3 | MM760 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 2.87e-04 | 171 | 20 | 3 | M40134 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 2.96e-04 | 436 | 20 | 4 | MM1326 | |
| Coexpression | GSE19512_NAUTRAL_VS_INDUCED_TREG_UP | 4.34e-04 | 197 | 20 | 3 | M8361 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 4.60e-04 | 201 | 20 | 3 | MM1294 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 6.81e-04 | 230 | 20 | 3 | MM986 | |
| Coexpression | HENDRICKS_SMARCA4_TARGETS_UP | 7.73e-04 | 54 | 20 | 2 | M15057 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 1.45e-06 | 191 | 20 | 4 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.97e-05 | 136 | 20 | 3 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | facs-Spleen-nan-24m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.30e-05 | 154 | 20 | 3 | bd283c2367afb99294e7576a0c0167eb7c69ad6b | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.99e-05 | 162 | 20 | 3 | 465cb483f41023d6125ea147e16f404d8e8dc9bb | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 188 | 20 | 3 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 188 | 20 | 3 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.77e-05 | 188 | 20 | 3 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 042391162df2e3d0027688dd14163c4c6821afe0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 71b0bfee0461ff64cef35881db3959c517e9731b | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-05 | 192 | 20 | 3 | 9d53b42cdb537b30233cdfdc08052c8b13a1113f | |
| ToppCell | facs-Thymus-Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.53e-05 | 194 | 20 | 3 | 255d6eead8da740a942a5e7d554dbd895d736d1a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.66e-05 | 195 | 20 | 3 | 81a98ebb0d43f416f9a8bba580531dc0cfea8f74 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 9.19e-05 | 199 | 20 | 3 | 399e73d45638848e68edda120316ceff04d98680 | |
| ToppCell | (06)_Krt4/13+-(2)_48hpi|(06)_Krt4/13+ / shred by cell type and Timepoint | 1.45e-04 | 40 | 20 | 2 | 1e42cd186ee06ac9345e16ede649a72c15bdf2f8 | |
| ToppCell | Thalamus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Slc17a6-Rora-Excitatory_Neuron.Slc17a6.Rora.Lypd6_(Parafasicular_nucleus_(PF))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 2.75e-04 | 55 | 20 | 2 | 7c8da8ca1776bb0abbfcf5c933b8817d64a0d3d7 | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Oncocytic_Type|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 9.23e-04 | 101 | 20 | 2 | 715d1c0192b9f397f285fe695950ca030af3233f | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Oncocytic_Type-6|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 9.23e-04 | 101 | 20 | 2 | b9df110a4dbd44d5e36a21ff976ffe5ef4e1c1c5 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Papillary_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.04e-03 | 107 | 20 | 2 | c3695771de30bd1d4da29ae97882f6d7dfdb2242 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-lymphocytic-B_lymphocytic-plasma_cell|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.36e-03 | 123 | 20 | 2 | 82a3867bf20470576eb54dcf61003bbccde7746e | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 1.43e-03 | 126 | 20 | 2 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Cytl1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.45e-03 | 127 | 20 | 2 | eee8e4a83f7de46807440d202d46eee7dd722001 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-03 | 138 | 20 | 2 | cd2f4682fcfd0275ce0640150bbb18da839e5c0a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-03 | 139 | 20 | 2 | c9bf98bed77415a1438f3f9e441a1346e75c26b0 | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 140 | 20 | 2 | 731b46e4b815a45af1d0ce7ab4d0d0324ac8798f | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 140 | 20 | 2 | b30fc389583406ee6cb55112d0f7250d1b74c88a | |
| ToppCell | facs-Lung-EPCAM-3m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-03 | 140 | 20 | 2 | 35ecd887bb7827603ef673912ba820208a6368d2 | |
| ToppCell | Healthy-B_cell|World / disease group, cell group and cell class | 1.91e-03 | 146 | 20 | 2 | 588359d3df6ad7090b7fa6c7f8d29cc1717e7f4f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.96e-03 | 148 | 20 | 2 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 1.99e-03 | 149 | 20 | 2 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.04e-03 | 151 | 20 | 2 | 32d35906f4b2bd46b173e87f2dec972eb5da87b3 | |
| ToppCell | COVID-19_Severe-multiplets|COVID-19_Severe / disease group, cell group and cell class | 2.07e-03 | 152 | 20 | 2 | 451745151322c2fcea22dbb3dba681e12634a510 | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-03 | 153 | 20 | 2 | 338684d420b01e32918fa19048ccdda234942ce1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c10-MKI67-GZMK|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.15e-03 | 155 | 20 | 2 | 5687416773809b8c478567bc54310af102b3029a | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.15e-03 | 155 | 20 | 2 | 62b59cb32b12bd55b19e98786a866d788fc9e4bf | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.18e-03 | 156 | 20 | 2 | 8790b4b400695571fcf1ccb24c658b5e90854ff7 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.21e-03 | 157 | 20 | 2 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.21e-03 | 157 | 20 | 2 | 2c946c6ab284fac3c25db688ed0aabe5a3f9ffa5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-03 | 159 | 20 | 2 | c960df9e4fa980401941866b5081facac4590b4d | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | c1d03c0ac9c12615a06499209fcdf18e9b6f1fba | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-03 | 160 | 20 | 2 | 41d6c811c445c0ba9b6a2deb10a3b6b793172582 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.32e-03 | 161 | 20 | 2 | a60ef3f390f56bb05b687b17986fe6382f69f260 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell-Endo|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-03 | 162 | 20 | 2 | 0bdb1e5ba33e162bec1acb28256c1405a7658ee5 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-03 | 162 | 20 | 2 | 2787be283b7a705647058aeb9bc54006ce5ffe95 | |
| ToppCell | primary_visual_cortex-Non-neuronal-endothelial_cell|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-03 | 162 | 20 | 2 | 5799a602ef8d83925907e8e34532428be7330228 | |
| ToppCell | COVID-19_Severe-multiplets|World / disease group, cell group and cell class | 2.37e-03 | 163 | 20 | 2 | 6db4271c2d47a9c333964f36d2c32207115e52cd | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.40e-03 | 164 | 20 | 2 | ec68954fc09b6850273b5e59caa6b09d02151097 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.40e-03 | 164 | 20 | 2 | 6a41a159134e605b80d5e731f9ed5bc803bb531b | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-03 | 165 | 20 | 2 | a74751e0ec857aa974bec04ccc747c004a8f6e01 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 166 | 20 | 2 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.46e-03 | 166 | 20 | 2 | f7926ee266dcbf10df375cd921f1db5a2fa604f8 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.46e-03 | 166 | 20 | 2 | 9d4b44eb56ad38c26aed73444edf389abca6bdf6 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-mature_enterocytic-Paneth|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.46e-03 | 166 | 20 | 2 | b64ab3d13b76bba3c305ebbfc96f983cd6ca30c9 | |
| ToppCell | frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.46e-03 | 166 | 20 | 2 | 27af6c906cff1d40d134f0386db7708869691121 | |
| ToppCell | facs-Large_Intestine-Proximal|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 168 | 20 | 2 | 23e0e1592d7400012d289adb10c7598285bae2e9 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 168 | 20 | 2 | 3bddf411a60137a8883fc9e77586e4719b0d6067 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-03 | 168 | 20 | 2 | ee4dab089adef2f47a9d39d91934523331a8b81c | |
| ToppCell | P28|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.52e-03 | 168 | 20 | 2 | 4ee59a6147bbe7e4a03cc2d6fe9d6c10b18a3a06 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-mature_enterocytic-Paneth|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-03 | 168 | 20 | 2 | 3e3f611e9bbec8224264666be14a4e7db343070e | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 168 | 20 | 2 | b6d948857ee652351ddbe383b75fdd1721cd8721 | |
| ToppCell | 3'-Adult-SmallIntestine-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.52e-03 | 168 | 20 | 2 | 4e2e4c88ada772e9ba6e72c9ae3a05c063e93318 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.55e-03 | 169 | 20 | 2 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-03 | 171 | 20 | 2 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.64e-03 | 172 | 20 | 2 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.64e-03 | 172 | 20 | 2 | c84cab89c97d647b8a256fd08e33d9102810febd | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-03 | 173 | 20 | 2 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.67e-03 | 173 | 20 | 2 | 3a9e9a09b3eeb37cbe56d650e112a8398879477f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | 3'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.67e-03 | 173 | 20 | 2 | b57d14e2c2368304cb903562d06ce8228f53857c | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | 9a04271c51fae34f547db3206f9ff5857686e45c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-03 | 173 | 20 | 2 | 3877cead288ce9509e6cccf57e55ec5e1bd7ce18 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.67e-03 | 173 | 20 | 2 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Endothelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | fbc8ed566ea36c39c258dd6b3823c82f5d6eb17f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-03 | 173 | 20 | 2 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.70e-03 | 174 | 20 | 2 | 40bb87d219aafab0357ab0d797efd38085fc0312 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.70e-03 | 174 | 20 | 2 | d77fa525d5c87c190b4a10787b270eabd16c610f | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-03 | 175 | 20 | 2 | c4088b5f9fa145869cf5dd8bee7680b1c8fada42 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 175 | 20 | 2 | 1c7725f917f3d6b9e0a31ede9524690f408a5ea1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.73e-03 | 175 | 20 | 2 | ca0d3e3a0a271cccdd3881b055fecb626712478d | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 175 | 20 | 2 | 78b453e220218c84557f244ef7a760e4a1952761 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-03 | 175 | 20 | 2 | c1a8a55af825d5913095f919fa860828df9c273e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.73e-03 | 175 | 20 | 2 | b9931455f232de3029510993015bb13b70dc18c9 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-03 | 175 | 20 | 2 | 0431897d7fcc9cefb516cd36987cf18b7f19a26a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-mature_enterocytic-Paneth|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.73e-03 | 175 | 20 | 2 | bffa623511ceb0b9bf76d87f9a10cfadfe0e940f | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-03 | 176 | 20 | 2 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | facs-Heart-RV-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-03 | 176 | 20 | 2 | 99410c121f55adbc7fcc013c8fa8905a45dba76b | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-03 | 176 | 20 | 2 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-nan|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-03 | 176 | 20 | 2 | 1dd54bfaa58541de51e5a8328651d390833bd480 | |
| ToppCell | facs-Heart-RV-18m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-03 | 176 | 20 | 2 | fb3d03f64592e1df1d9785d9f2e70938d7ff9ce8 | |
| ToppCell | facs-Heart-RV-18m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-03 | 176 | 20 | 2 | 3270a36fc91a5583646ffeb70bfcbc5af7292aac | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_vein|Adult / Lineage, Cell type, age group and donor | 2.76e-03 | 176 | 20 | 2 | 043683c61c5d1a7f8a4666a612310246bd3d83a2 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-03 | 177 | 20 | 2 | ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.79e-03 | 177 | 20 | 2 | 12f8627124acbf436e75681ff1ce429ff5e3f256 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-03 | 177 | 20 | 2 | a0b172f40e0df97a288a5549ae7066697ad469b3 | |
| ToppCell | droplet-Tongue-nan-3m-Myeloid-Langerhans_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-03 | 177 | 20 | 2 | 34bd46704827c9db7053bbd0c671dd0b661b79b4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-03 | 177 | 20 | 2 | f471f7747d6e8db7546899019af9508f48a14f89 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.79e-03 | 177 | 20 | 2 | ab8f09e118e4df696b0b4d33f013da020bdbd351 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.79e-03 | 177 | 20 | 2 | 5ff8dcfb030312126695d53a026d2e104a401b83 | |
| Computational | Neighborhood of CDKN1C | 3.98e-06 | 27 | 13 | 3 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 6.72e-06 | 32 | 13 | 3 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 8.85e-06 | 35 | 13 | 3 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.54e-05 | 42 | 13 | 3 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 2.04e-05 | 46 | 13 | 3 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.47e-05 | 49 | 13 | 3 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 6.99e-06 | 43 | 20 | 3 | CID000004683 | |
| Drug | didansylcadaverine | 2.05e-05 | 8 | 20 | 2 | CID000108731 | |
| Drug | cadaverine | 3.06e-05 | 70 | 20 | 3 | CID000000273 | |
| Drug | dapsone | 3.47e-05 | 73 | 20 | 3 | CID000002955 | |
| Drug | 1-(5-aminopentyl)-3-phenylthiourea | 4.01e-05 | 11 | 20 | 2 | CID003035524 | |
| Drug | Tg 5 | 4.81e-05 | 12 | 20 | 2 | CID000205491 | |
| Drug | 1,10-diaminodecane | 5.68e-05 | 13 | 20 | 2 | CID000001317 | |
| Drug | 5-(biotinamido)pentylamine | 6.63e-05 | 14 | 20 | 2 | CID000083906 | |
| Drug | 2-acetylaminofluorene | 7.18e-05 | 262 | 20 | 4 | CID000005897 | |
| Drug | monodansylthiacadaverine | 9.89e-05 | 17 | 20 | 2 | CID000162694 | |
| Drug | dansyl chloride | 1.12e-04 | 108 | 20 | 3 | CID000011801 | |
| Drug | tryptophanyl-5'AMP | 1.83e-04 | 23 | 20 | 2 | CID000446202 | |
| Drug | carbonyl sulfide | 2.11e-04 | 134 | 20 | 3 | ctd:C010063 | |
| Drug | 2',3'-epoxypropyl alpha-D-glucopyranoside | 2.35e-04 | 26 | 20 | 2 | CID000193692 | |
| Drug | GMBS | 2.54e-04 | 27 | 20 | 2 | CID000133440 | |
| Drug | sulfapyridine | 2.54e-04 | 27 | 20 | 2 | CID000005336 | |
| Disease | cD177 antigen measurement | 2.16e-07 | 18 | 20 | 3 | EFO_0021866 | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 2.62e-06 | 4 | 20 | 2 | EFO_0801909 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 6.54e-06 | 6 | 20 | 2 | EFO_0801907 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 9.15e-06 | 7 | 20 | 2 | EFO_0801906 | |
| Disease | diastolic blood pressure, systolic blood pressure | 9.96e-03 | 670 | 20 | 3 | EFO_0006335, EFO_0006336 | |
| Disease | HbA1c measurement | 1.02e-02 | 675 | 20 | 3 | EFO_0004541 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFWNYSPDTMNGSWS | 371 | Q9HBW9 | |
| YGETPETSFNQWAWN | 956 | Q9HCE0 | |
| WYWGANDSAGNMIIS | 61 | A8MTB9 | |
| ASNYAEPPWALSNWM | 506 | Q9N2K0 | |
| WAAANYANAHPWQQM | 16 | Q7L3V2 | |
| MDWNEASSAPGYNWN | 1206 | Q5TGY3 | |
| SNPWISDNDAYWVMN | 271 | O94810 | |
| YWNNGAETSWQIMAN | 171 | Q460N3 | |
| AANWMESSSWDGRYA | 176 | P54868 | |
| NWSAPRDAYWIAMNS | 106 | O75794 | |
| MEGYQSWTLANGWNS | 226 | P35453 | |
| DMWHYAGDQSTDFNW | 226 | O75208 | |
| QMDNPCSSWLADAYW | 3721 | Q9P225 | |
| PATPAASYQWWMNGQ | 171 | Q00888 | |
| NGEGWEWSSSDVMNY | 116 | Q06141 | |
| WGDPSNYNNKTVNMW | 731 | Q9HCJ0 | |
| PETLDASYLWWMNGQ | 171 | Q00887 | |
| MEASWGSFNAERGWY | 1 | Q8IZM9 | |
| WDNNYGDGVSPMSWI | 241 | P21980 | |
| NWSENYTDGANPAEW | 241 | O43548 | |
| PETPDTSYQWWMNGQ | 171 | P11465 |